BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Febit, Inc. Launches Whole Genome Sequencing Service in Europe


3/23/2010 1:25:49 PM

LEXINGTON, Mass. (USA), and HEIDELBERG, Germany, March 22, 2010 – febit today announced that the company now offers whole genome sequencing services in Europe for a broad range of species. febit is known for its reliable and accurate targeted resequencing services and instruments for genome exploration.

febit has acquired two Applied Biosystems SOLiD™ high-throughput sequencing systems from Life Technologies Corporation (Nasdaq: LIFE), necessary for whole genome resequencing. One of the two systems will be used within R&D while the other is employed within febit’s Genomic Service Department. Life Technologies is a global biotechnology tools company providing premier systems, consumables, and services for scientific researchers around the world. “We combine our expertise in optimizing samples for highest coverage in targeted resequencing with the established SOLiD sequencing power,” said Peer Staehler, CSO of febit. “This will enable us to offer whole genome sequencing at very competitive prices; the price for resequencing a whole human genome will start at 9,750 Euro. The ultra-deep resequencing with 99.94 % accuracy allows confident SNP and mutation detection as well as the detection of structural variations such as insertions, deletions, inversions and translocations.”

The new whole genome resequencing service extends febit’s service portfolio which is already well established for targeted resequencing of genomic regions of interest with its high throughput HybSelect-technology. Together with a barcoding option, febit’s new service portfolio will advance the use of next-generation sequencing for larger scale clinical studies due to effective costs and data management.

About febit

febit develops, produces and markets automated solutions for researchers in the life sciences to explore the genome. The high degree of automation offers the customers of febit’s instruments ease of use as well as results of highest quality: for febit’s targeted resequencing protocol on the HybSelector or miRNA profiling on the Geniom® RT Analyzer. febit’s service customers can benefit from the simplified, automated solutions by ordering hybselected parts of the genome for targeted resequencing conducting statistically relevant large scale studies with hundreds of samples or whole genome resequencing for a reasonable price. febit’s miRNA profiling service, e.g. for biomarker discovery, lead to publication ready results by offering a sophisticated bioinformatics report. For more information, please visit www.febit.com.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES